« Previous
Next »
Journal of Dentistry
Volume 38, Issue 1
, Pages 10-15
, January 2010
Levels of salivary IgA antibodies to Candida spp. in HIV-infected adult patients: A systematic review
References
- . Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infection and Immunity. 1994;62:892–896
- . Salivary defence factor concentrations in relation to oral and general parameters in HIV positive patients. European Journal of Oral Sciences. 1998;106:979–985
- . Oral manifestations and dental status in paediatric HIV infection. International Journal of Paediatric Dentistry. 2000;10:3–11
- . Oral soft tissue manifestation in HIV-positive vs HIV-negative children from an inner city population: a two-year observational study. Pediatric Dentistry. 2000;22:215–220
- . Frequency of oral manifestations in children infected with human immunodeficiency virus. Quintessence International. 2000;31:419–422
- . Manifestações estomatológicas, contagem de linfócitos T-CD4+ e carga viral de crianças brasileiras e norte-americanas infectadas pelo HIV. Pesquisa Odontológica Brasileira. 2002;16:18–25
- . The role of saliva in maintaining oral homeostasis. Journal of the American Dental Association. 1989;119:298–304
- . Protection against enteric bacterial infection by secretory IgA antibodies. Journal of Immunology. 1973;111:395–403
- . Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells. Infection and Immunity. 1978;22:790–797
- . Effects of specific antibodies on the interaction between the fungus Candida albicans and human oral mucosa. Archives of Oral Biology. 1982;17:469–474
- . The effect of secretory immunoglobulin A on the in-vitro adherence of the yeast Candida albicans to human oral epithelial cells. Archives of Oral Biology. 1982;27:617–621
- . Alteration of humoral responses to Candida in HIV infection. British Dental Journal. 1990;168:326–329
- Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era. Mycopathologia. 2006;162:45–50
- Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons. Revista Iberoamericana de Micología. 2005;22:83–92
- Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis. Clinical Chemistry and Laboratory Medicine. 2001;39:519–526
- . Whole and parotid saliva IgA and IgA-subclass responses to Candida albicans in HIV infection. Advances in Experimental Medicine and Biology. 1995;371B:1031–1034
- . A comprehensive study of Candida-specific antibodies in the saliva of human immunodeficiency virus-positive individuals with oropharyngeal candidiasis. The Journal of Infectious Diseases. 2002;185:1269–1276
- . Elevation of salivary antimicrobial proteins following HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes. 1990;3:41–48
- Longitudinal study of anti-Candida albicans mucosal immunity against aspartic proteinases in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes. 2001;26:137–144
- . Immunologic aspects of oral candidiasis. Oral Surgery, Oral Medicine, and Oral Pathology. 1994;78:202–210
- Salivary anticandidal activity and saliva composition in an HIV-infected cohort. Oral Microbiology and Immunology. 2001;16:270–278
- . Relationship between oral Candida and salivary antimicrobial proteins in HIV-positive individuals. Journal of Tokyo Medical University. 2004;62:625–634
- . Salivary IgA and serum IgA and IgG antibodies to Candida albicans in HIV-infected subjects. International Journal of STD & AIDS. 2002;13:373–377
- Associations among the use of highly active antiretroviral therapy, oral candidiasis, oral Candida species and salivary immunoglobulin A in HIV-infected children. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 2009;108:203–210
- Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. BMC Oral Health. 2006;6:1–9
- . Oral lesions in brazilian HIV-infected children undergoing HAART. International Journal of Pediatric Otorhinolaryngology. 2006;70:1089–1096
- . The epidemiology of the oral lesions of HIV infection in the developed world. Oral Diseases. 2002;8:34–39
- Prevalence of oral lesions in Mexican children with perinatally acquired HIV: association with immunologic status, viral load, and gender. AIDS Patient Care STDS. 2002;16:151–156
- . Pediatric HIV-related oral manifestations—a five-year retrospective study. Brazilian Oral Research. 2004;18:6–11
- HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro. FEMS Immunology and Medical Microbiology. 2001;31:65–71
- Nonspecific secretory immunity in HIV-infected patients with oral candidiasis. Journal of Acquired Immune Deficiency Syndromes. 2002;31:276–284
- . Salivary IgA to cariogenic bacteria in HIV-positive children and its correlation with caries prevalence and levels of cariogenic microorganisms. Oral Microbiology and Immunology. 2004;19:1–8
PII: S0300-5712(09)00213-9
doi: 10.1016/j.jdent.2009.09.005
© 2009 Elsevier Ltd. All rights reserved.
« Previous
Next »
Journal of Dentistry
Volume 38, Issue 1
, Pages 10-15
, January 2010
